Loratadine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Loratadine Market is Segmented by Type (Tablets, Capsules, and Syrup), Application, and Geography.

Market Snapshot

Market Snapshot clarityne
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The loratadine market is primarily driven by the change in lifestyle, a growing burden of allergies which trigger the hypersecretion of histamine. According to the American Academy of Allergy, Asthma & Immunology (AAAI), worldwide, sensitization (IgE antibodies) to foreign proteins in the environment is present in up to 40% of the population. Allergic rhinitis affects between 10 to 30 percent of the population. Moreover, wide applications of the drug coupled with the growing usage of loratadine in various types of allergies are anticipated to boost the market growth over the forecast period. In addition, continuous development in loratadine drugs is projected to drive the growth of the market. However, stringent regulatory policies anticipated to hinder the market growth over the period.

Scope of the Report

Loratadine is the long-acting, non-sedating antihistamine drug that is used in the treatment of allergies. Histamine is the primary cause of many symptoms of allergy. Loratadine is generally used in the treatment of hay fever, urticaria, allergic skin rash, and other allergies.

By Type
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Tablets Anticipated to Have Significant Market Growth

Loratadine tablets are anticipated to have a significant share of the types of drugs. This is primarily due to ease of administration and availability of huge approved tablet forms. The drug is used with various combinations such as pseudoephedrine, ambroxol, and others in the treatment of cough and other related allergies. According to the European Centre for Allergy Research Foundation, urticaria is the most common type of allergy and it occurs in over 20% of the population in their lifetime.

The factors such as rapid climate change, increase in grass pollen production are primary causing factors for many allergies such as hay fever, allergic conjunctivitis, and others. Moreover, growing R&D initiatives to test the various combinations of loratadine in the treatment of diseases anticipated to fuel the market growth over the forecast period.

Clarityn Trends.png

North America is Anticipated to Have Significant Growth

Among the regions, North America is anticipated to have a significant growth rate owing to well-established healthcare infrastructure, presence of key market players manufacturing and marketing loratadine and high prevalence of allergies in the region. In addition, the growing adaptation of loratadine and active pipelines is anticipated to boost the regional growth over the forecast period. According to AAAI (American Academy of Allergy, Asthma, and Immunology), approximately 7.8% of the people in the United States over 18 years of age are having hay fever. On the other hand, Asia Pacific is anticipated to have lucrative market growth owing to changing lifestyles, the presence of many generic manufacturers and the developing healthcare industry.

Loratadine geo.png

Competitive Landscape

The global loratadine market is highly fragmented and competitive. Market players are focusing on new product launches, product innovations and geographical expansion to strengthen its market share. The key market players operating in the market include Bayer AG, Cadila Pharmaceuticals, Morepen Laboratories Ltd, Mylan N.V. and Pfizer Inc. among others

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Allergies Around the World

      2. 4.2.2 Research and Development in Loratadine Combinations

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects and Availability of Alternatives

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Tablets

      2. 5.1.2 Capsules

      3. 5.1.3 Syrup

    2. 5.2 By Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Rest of the World


    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Cadila Pharmaceuticals

      3. 6.1.3 Morepen Laboratories Ltd

      4. 6.1.4 Mylan N.V.

      5. 6.1.5 Pfizer Inc.

      6. 6.1.6 Perrigo Company PLC

      7. 6.1.7 Sun Pharmaceutical Industries Limited

    2. *List Not Exhaustive

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Loratadine Market market is studied from 2018 - 2026.

The Loratadine Market is growing at a CAGR of 2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bayer AG , Mylan N.V., Pfizer Inc. , Cadila Pharmaceuticals, Sun Pharmaceutical Industries Ltd. are the major companies operating in Loratadine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!